MENU
CGEN
AS OF
Dec 24 closing price
Price
$1.54
Change
+$0.02 (+1.32%)
Capitalization
143.21M
56 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Compugen (CGEN) Ownership - Who owns Compugen?

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
26 Harokmim Street
Phone
+972 37658585
Employees
68
Web
https://www.cgen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
143.21M
P/E Ratio
64.00
Total Cash
86.09M
Projected Growth
N/A
Total Debt
2.95M
Revenue
6.9M
Risk (Beta)
3.42
Dividend Yield
N/A
Total Cash/Share
0.92
Total Debt/Equity
N/A
Revenue/Share
0.07 USD as % of share price

Fundamentals

CGEN
Capitalization
143M
P/E Ratio
64.00
Risk (Beta)
3.42
Dividend Yield
N/A
Total Cash
86.1M
Total Cash/Share
0.92
Total Debt
2.95M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.07%
Revenue
6.9M
ROE
N/A
Book Value
43.8M
P/B Ratio
3.29
Cash Flow
N/A
Earnings
-0.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
248K
Current Ratio
4.38
Current Revenue Per Employee
25554.06
Dividends Per Share - Security
N/A
EBITDA
-32.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
12.74
Revenue To Assets
-24.95
Shares Held By Institutions
8.09M
Shares Outstanding - Current
93.5M
Total Liabilities
54M
Total Volume MTD
N/A
Value
-1
Gain YTD
0.654
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CGEN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CGEN showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for CGEN
A.I. Advisor
published General Information

General Information

a maker of drug and diagnostics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
26 Harokmim Street
Phone
+972 37658585
Employees
68
Web
https://www.cgen.com